TrackStar Preview: Healthcare Stocks See Surge in Advisor Interest

[Click to view in browser](. Jan 6th 2020 Dear InvestingChannel Reader, Welcome back to TrackStar: the only newsletter tracking the behavior of the most powerful market participants and the information they consume. TrackStar’s elite sourcing technology allows you to see what verified Financial Professionals are researching. We saw advisor interest soar last week among a number of healthcare companies: - [Intra-Cellular Therapies]( - [Microbot Medical Inc]( - [Rite Aid Corporation]( Stay tuned tomorrow for the full dataset of top researched tickers. [When Options Cash Settlement Really Matters]( Options may be cash settled or physically delivered. ETF options, like SPY, expire into ETF shares. Index options, like the comparable Mini-SPX, are cash settled. Learn why this key difference is particularly important when it comes to “gap risk.” [Click here to read more.]( Sponsored by CBOE It should come as no surprise that there is institutional interest in Intra-Cellular Therapies given recent FDA approval of their new treatment. [Intra-Cellular Therapies (ITCI) Receives FDA Approval of Novel Antipsychotic, CAPLYTA for Treatment of Schizophrenia in Adults]( [(Street Insider)]( The efficacy of CAPLYTA 42 mg was demonstrated in two placebo-controlled trials, showing a statistically significant separation from placebo on the primary endpoint, the Positive and Negative Syndrome Scale (PANSS) total score. The most common adverse reactions (≥5% and twice the rate of placebo) for the recommended dose of CAPLYTA vs placebo were somnolence/sedation (24% vs.10%) and dry mouth (6% vs. 2%). [Click here to read more.]( Barchart has full coverage of Microbot Medical Inc.’s recent direct offering that has Wall Street buzzing. [Microbot Medical Inc. Announces Closing Of Registered Direct Offering Of Common Stock]( [(Barchart)]( Microbot currently intends to use the net proceeds from this offering for the continuous development and regulatory activities for its SCS device for the treatment of hydrocephalus and NPH; continue the development of the Company's LIBERTY robotic system, including its expansion through the addition of complementary assets to it either through internal development, in-license or acquisitions; expand and develop additional applications deriving from its existing IP portfolio, either through internal development, in-license or acquisition; and for working capital and other general corporate purposes. [Click here to read more.]( [Legendary Stock-Picker Names Favorite Stock of 2020]( 200 stocks he’s recommended soared 100% or more. Sixteen recommendations soared 1,000% or more. And he just went public with his [#1 pick for the new year.]( Sponsored by Stansberry Research Todd Shriber brings us an analysis of historical sector ETF performance for January. Healthcare is highlighted as the best performing sector for the month. [Best Sector ETFs For January: Energy, Health Care In Focus]( [(Benzinga)]( XLV, the largest health care ETF, averages a January gain of around 1%, according to CXO Advisory data. Last year, XLV gained 20.4%, trailing the S&P 500, which rose 31.2%. January is one of four months in which XLV ranks as one of the best sector SPDRs, notes CXO. [Click here to read more.]( [The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger]( by [Benzinga]( Agile Therapeutics Inc (NASDAQ: AGRX (announced the appointment of healthcare industry veteran Kimberly Whelan as VP, Market Access, as it prepares for a potential Twirla commercial launch) [Read more.]( [Order Your Book by Former White House Insider, David Stockman Now – Free Shipping]( Sponsored by [Charles Street Research]( - Why the “trump boom” has been a complete lie - How America blew its LAST shot at saving our financial future - Why the mainstream media WON’T get their wish to bring down trump Pay just $10 for the book and shipping is FREE – a $26 value on Amazon. [Read more.]( [FDA Set To Ban Flavored E-Cigarette Pods]( by [Benzinga]( The update in policy, which the Journal said could come as soon as Friday, is intended to curb a surge in underage vaping and will be applied to pod-based vaporizers, including those made by Juul, NJOY Holdings Inc. and Reynolds American Inc. The ban will include mint, but allows menthol- and tobacco-flavored e-cigarette pods to remain on store shelves, the Journal reported. [Read more.]( Copyright 2019, Investing Channel, All Rights Reserved | [Privacy Policy]( [InvestingChannel, Inc.]( P.O. Box 118 New York, NY 10018. To unsubscribe, [click here]( [Link](